The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 63 results:
Author Title Type [ Year(Desc)]
Filters: Keyword is Renal Insufficiency, Chronic  [Clear All Filters]
2011
Iliadis, F., Didangelos T., Ntemka A., Makedou A., Moralidis E., Gotzamani-Psarakou A., et al. (2011).  Glomerular filtration rate estimation in patients with type 2 diabetes: creatinine- or cystatin C-based equations?. Diabetologia. 54(12), 2987-94.
2013
Kirmizis, D., Papagianni A., Dogrammatzi F., Efstratiadis G., & Memmos D. (2013).  Anti-inflammatory effects of simvastatin in diabetic compared to non-diabetic patients on chronic hemodialysis.. J Diabetes. 5(4), 492-4.
Gorostidi, M., Sarafidis P. A., de la Sierra A., Segura J., de la Cruz J. J., Banegas J. R., et al. (2013).  Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.. Am J Kidney Dis. 62(2), 285-94.
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.
Borzych-Duzalka, D., Bilginer Y., Ha I. Soo, Bak M., Rees L., Cano F., et al. (2013).  Management of anemia in children receiving chronic peritoneal dialysis.. J Am Soc Nephrol. 24(4), 665-76.
Pipili, C. L., Papatheodoridis G. V., & Cholongitas E. C. (2013).  Treatment of hepatitis B in patients with chronic kidney disease.. Kidney Int. 84(5), 880-5.
Cannata-Andia, J. B., Fernández-Martín J. L., Locatelli F., London G., Gorriz J. L., Floege J., et al. (2013).  Use of phosphate-binding agents is associated with a lower risk of mortality.. Kidney Int. 84(5), 998-1008.
2014
Sarafidis, P. A., & Ruilope L. M. (2014).  Aggressive blood pressure reduction and renin-angiotensin system blockade in chronic kidney disease: time for re-evaluation?. Kidney Int. 85(3), 536-46.
Sarafidis, P. A., & Ruilope L. M. (2014).  The authors reply.. Kidney Int. 86(4), 855.
Sarafidis, P. A., Georgianos P. I., & Zebekakis P. E. (2014).  Comparative epidemiology of resistant hypertension in chronic kidney disease and the general hypertensive population.. Semin Nephrol. 34(5), 483-91.
Papademetriou, V., Doumas M., Anyfanti P., Faselis C., Kokkinos P., & Tsioufis C. (2014).  Renal nerve ablation for hypertensive patients with chronic kidney disease.. Curr Vasc Pharmacol. 12(1), 47-54.
Pipili, C., Cholongitas E., & Papatheodoridis G. (2014).  Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease.. Aliment Pharmacol Ther. 39(1), 35-46.
Tziomalos, K., Giampatzis V., Baltatzi M., Efthymiou E., Psianou K., Papastergiou N., et al. (2014).  Sex-specific differences in cardiovascular risk factors and blood pressure control in hypertensive patients.. J Clin Hypertens (Greenwich). 16(4), 309-12.
Athyros, V. G., & Mikhailidis D. P. (2014).  Uric acid, chronic kidney disease and type 2 diabetes: a cluster of vascular risk factors.. J Diabetes Complications. 28(2), 122-3.
2015
Sarafidis, P. A., Georgianos P. I., & Bakris G. L. (2015).  Advances in treatment of hyperkalemia in chronic kidney disease.. Expert Opin Pharmacother. 16(14), 2205-15.
Georgianos, P. I., Sarafidis P. A., & Liakopoulos V. (2015).  Arterial Stiffness: A Novel Risk Factor for Kidney Injury Progression?. Am J Hypertens. 28(8), 958-65.
Sarafidis, P. A., & Bakris G. L. (2015).  Cardiovascular disease in CKD in 2014: new insights into cardiovascular risk factors and outcomes.. Nat Rev Nephrol. 11(2), 70-2.
Athyros, V. G., Tziomalos K., Katsiki N., Doumas M., Karagiannis A., & Mikhailidis D. P. (2015).  Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update.. World J Gastroenterol. 21(22), 6820-34.
Gkogka, C., Christoforidis A., Printza N., Kollios K., Kazantzidou E., & Papachristou F. (2015).  Longitudinal assessment of bone quality in pediatric patients with chronic kidney disease in relation to treatment modality.. J Bone Miner Metab. 33(3), 303-10.
Giagtzidis, I., Karkos C., Pitoulias G., & Papazoglou K. (2015).  Matrix metalloproteinases and peripheral arterial disease.. Int Angiol. 34(3), 195-201.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opin Pharmacother. 16(10), 1449-61.
Athyros, V. G., Tziomalos K., & Karagiannis A. (2015).  Treatment options for dyslipidemia in chronic kidney disease and for protection from contrast-induced nephropathy.. Expert Rev Cardiovasc Ther. 13(9), 1059-66.
2016
Ruiz-Hurtado, G., Sarafidis P., Fernández-Alfonso M. S., Waeber B., & Ruilope L. M. (2016).  Global cardiovascular protection in chronic kidney disease.. Nat Rev Cardiol. 13(10), 603-8.
Bakr, N. Abu, Torsello G., Pitoulias G. A., Stavroulakis K., Austermann M., & Donas K. P. (2016).  Preservation of Clinically Relevant Accessory Renal Arteries in Infrarenal AAA Patients With Adequate Proximal Landing Zones Undergoing EVAR.. J Endovasc Ther. 23(2), 314-20.
Dotis, J., Pavlaki A., Printza N., Stabouli S., Antoniou S., Gkogka C., et al. (2016).  Quality of life in children with chronic kidney disease.. Pediatr Nephrol. 31(12), 2309-2316.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.